As per the GOI circular on price capping of Orthopaedic Knee implant by NPPA(National Pharmaceutical Pricing Authority), new prices of knee implants have been implemented effective 16th August 2017. For details on knee implant pricing across our hospitals. CLICK HERE | As per GOI’s circular on price-capping of stents by NPPA(National Pharmaceutical Pricing Authority), new prices of coronary stents have been implemented effective 14th February, 2017. For details on stent pricing, across our hospitals. CLICK HERE
Doctor Profile
Dr. Anil Abrol

Dr. Anil Abrol, MD

6+ Years Of Experience

Consultant - Fortis Hospital, Mohali

Rheumatology

OPD Schedule - +91 172 469 2222, +91 172 502 1222

  • Mon

    11:00 AM - 03:00 PM

  • Tue

    11:00 AM - 03:00 PM

  • Wed

    11:00 AM - 03:00 PM

  • Thu

    11:00 AM - 03:00 PM

  • Fri

    11:00 AM - 03:00 PM

  • Sat

    11:00 AM - 03:00 PM


  • Request Appointment

Dr Anil Abrol is a post graduate in Internal Medicine & an Ex-Registrar, PGIMER, Chandigarh (Rheumatology services). Subsequently, he pursued a Fellowship in Rheumatology and also worked in Department of Rheumatology at Fortis Flt Lt Rajan Dhall Hospita, Vasant Kunj, New Delhi. He is a Fellow of Academy of General Education (FAGE), European League Against Rheumatism (EULAR) and a member of Indian Rheumatology Association (IRA). He has a significant contribution to academics and research work. He has many International and National research papers in Rheumatology and a Chapter in a book to his credit. He has been a co-investigator in drug trials such as Infliximab bio similar and Etanercept bio similar. Dr Abrol has worked in state-of-art Rheumatology facilities & attained expertise in management of rheumatoid arthritis, spondyloarthritis/ankylosing spondylitis, psoriatic arthritis, reactive arthritis, SLE, Sjogren’s Syndrome, scleroderma, Polymyositis/Dermatomyositis, Vasculitides (eg Wegener’s granulomatosis, polyarteritis nodosa), and other disorders of joint/adjacent tissues such as osteoarthritis, crystal associated arthropathies, fibromyalgia etc. He underwent specialized training in administration of biological drugs viz. Infliximab, Etanercept, Rituximab etc. He
is well versed with synovial joint aspirations, soft tissue, intra-articular injections and rehabilitation of rheumatology patients.
Designation: Consultant
Department/Specialty: Rheumatology

Languages spoken: English, Hindi, Punjabi, Pahari, Kannada
Total Years’ of Experience: 6+
Medical Education, Certifications and fellowships/Research Papers:
Professional Memberships: Indian Rheumatology Association (Life Member)
Clinical Interests/ Specialised Treatments /Area of Expertise:
Research and Publications:
Chapter in book:  Rheumatoid Arthritis and Pregnancy. Rheumatic Diseases in Women & Children Current perspectives, I edition, Sect 1 Ch1, 3-9
International:

 A letter to the editor. Coronary spasm due to infliximab in a patient of Ankylosing Spondylitis. International journal of Rheumatic Diseases. 2013April;16,235-236

 Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009–2010. Histopathology2012; 60, 326–335

 A letter to the editor. A case of incapacitating back pain due to axial gout. International journal of Rheumatic Diseases.

National Publications:

 What is your diagnosis? A rare cause of polyarthritis with myositis. Indian Journal of Rheumatology 2012 March ;7, 44–45

 Original article. Vitamin D deficiency as the primary cause of musculoskeletal complaints in patients referred to rheumatology clinic: A clinical study. Indian Journal of Rheumatology 2012 December; 7, 199-203

 What is your diagnosis? A middle aged man with bluish-black skin pigmentation and polyarthritis. Indian Journal of Rheumatology 2012 December; 7, 230-232

 Abstract. Clinical audit on 100 patients with rheumatoid arthritis seen in rheumatology clinic. Indian Journal of Rheumatology 2012 November;7, P98

 Abstract. A case of incapacitating back pain due to axial gout. Indian Journal of Rheumatology 2012 November;7, P111

Clinical trials :
 Co-investigator in Infliximab Biosimilar (Epirus Biopharmaceuticals / Reliance) clinical trial at Fortis Vasant Kunj

 Participated in Etanercept Biosimilar (Zenotech pharma) clinical trial at Fortis Vasant Kunj
Medical Breakthroughs/ Interesting Case Studies: